Rhinomed secures US retail deal
0 mins. to read
Australian-listed medical devices manufacturer and Master Investor Show 2018 exhibitor Rhinomed (ASX:RNO) has scored a deal with a major US pharmacy that will see its Mute range of products sold in more than 3,000 outlets across the states.
Get the latest from Master Investor directly in your inbox – Sign-up HERE for FREE
The identity of the other party can’t be revealed until merchandise is about to hit the shelves later this summer, but they have placed an initial order of 6,000 units and Rhinomed expect further orders to follow. CEO Michael Johnson said, “This is a critical step in our strategy of ensuring that our retail footprint increases in the significant American market”.
Comments (0)